Mutation analysis of circulating plasma DNA to determine response to EGFR tyrosine kinase inhibitor therapy of lung adenocarcinoma patients

相似書籍

• Low Input Whole-Exome Sequencing to Determine the Representation of the Tumor Exome in Circulating DNA of Non-Small Cell Lung Cancer Patients
  由: Dietz, Steffen, et al.
  出版: (2016)
• Assessment of EGFR gene mutations in circulating free DNA in monitoring of response to EGFR tyrosine kinase inhibitors in patients with lung adenocarcinoma
  由: Nicoś, Marcin, et al.
  出版: (2019)
• Molecular signatures in IASLC/ATS/ERS classified growth patterns of lung adenocarcinoma.
  由: Heike Zabeck, et al.
  出版: (2018-01-01)
• Molecular signatures in IASLC/ATS/ERS classified growth patterns of lung adenocarcinoma
  由: Zabeck, Heike, et al.
  出版: (2018)
• EGFR Mutation Heterogeneity and the Mixed Response to EGFR Tyrosine Kinase Inhibitors of Lung Adenocarcinomas
  由: Chen, Zhi-Yong, et al.
  出版: (2012)